Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOVIE INC. | 57,500 | reported | 05 Jan 2026 | tx 1+57,500 |
| Akari Therapeutics Plc | 24,745 | reported | 16 Dec 2025 | tx 5+114,386 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jan 2026 | GRANT_AWARD | BIOVIE INC. | 57,500 | 0.00 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 24,745 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 24,745 | — | deriv |
| 01 Nov 2025 | GRANT_AWARD | Akari Therapeutics Plc | 26,619 | 0.75 USD | |
| 01 Nov 2025 | GRANT_AWARD | Akari Therapeutics Plc | 32,000 | 0.75 USD | |
| 22 Oct 2025 | GRANT_AWARD | Akari Therapeutics Plc | 6,277 | 0.74 USD |